Xeris Biopharma Holdings (XERS) EPS (Diluted) (2021 - 2026)
Xeris Biopharma Holdings (XERS) EPS (Diluted) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | -0.49 |
| 3 | Zoetis | 31.79 Bn | 30.11 Bn | 1.05 Bn | 2.07 |
| 4 | Takeda Pharmaceutical | 28.69 Bn | 22.89 Bn | 5.10 Bn | 0.45 |
| 5 | United Therapeutics | 22.25 Bn | 19.58 Bn | 683.80 Mn | 7.27 |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -0.10 |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | 1.39 |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 0.11 |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Xeris Biopharma Holdings | 1.51 Bn | 1.39 Bn | 79.59 Mn | -0.18 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.18 |
| Mar 31, 2026 | 0.01 |
| Dec 31, 2025 | 0.06 |
| Sep 30, 2025 | 0.00 |
| Jun 30, 2025 | -0.01 |
| Mar 31, 2025 | -0.06 |
| Dec 31, 2024 | -0.03 |
| Sep 30, 2024 | -0.11 |
| Jun 30, 2024 | -0.10 |
| Mar 31, 2024 | -0.14 |
| Dec 31, 2023 | -0.10 |
| Sep 30, 2023 | -0.09 |
| Jun 30, 2023 | -0.14 |
| Mar 31, 2023 | -0.12 |
| Dec 31, 2022 | -0.10 |
| Sep 30, 2022 | -0.16 |
| Jun 30, 2022 | -0.19 |
| Mar 31, 2022 | -0.25 |
| Dec 31, 2021 | -0.64 |
| Sep 30, 2021 | -0.39 |